Global Pediatric Drugs and Vaccines Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027
Date: May-2021 | Id: MACRC-64405 | Geographical Scope: Global | Publisher: HNY Research
The global Pediatric Drugs and Vaccines market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on Mnemonics Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). By Market Verdors: Merck & Co., Inc. (USA) Abbott Laboratories (USA) Amgen, Inc. (USA) Eli Lilly and Company (USA) F. Hoffmann-La Roche Ltd (Switzerland) Genentech, Inc. (USA) GlaxoSmithKline plc. (UK) Janssen Biologics B.V. (USA) Actelion Pharmaceuticals AstraZeneca Plc. (UK) Boehringer Ingelheim GmbH (Germany) Bristol-Myers Squibb Company (USA) Allergan, Inc. (USA) Novartis AG (Switzerland) Novo Nordisk A/S (Denmark) Pfizer, Inc. (USA) Sanofi S.A (France) Shionogi Inc. (USA) Shire Pharmaceuticals Group Plc. (UK) By Types: Diphtheria Influenza Hepatitis Pneumococcal Diseases Meningococcal Diseases Mumps Others By Applications: Newborn Infant Child Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Pediatric Drugs and Vaccines Revenue 1.5 Market Analysis by Type 1.5.1 Global Pediatric Drugs and Vaccines Market Size Growth Rate by Type: 2021 VS 2027 1.5.2 Diphtheria 1.5.3 Influenza 1.5.4 Hepatitis 1.5.5 Pneumococcal Diseases 1.5.6 Meningococcal Diseases 1.5.7 Mumps 1.5.8 Others 1.6 Market by Application 1.6.1 Global Pediatric Drugs and Vaccines Market Share by Application: 2022-2027 1.6.2 Newborn 1.6.3 Infant 1.6.4 Child 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Pediatric Drugs and Vaccines Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter’s Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Pediatric Drugs and Vaccines Market Players Profiles 3.1 Merck & Co., Inc. (USA) 3.1.1 Merck & Co., Inc. (USA) Company Profile 3.1.2 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Specification 3.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.2 Abbott Laboratories (USA) 3.2.1 Abbott Laboratories (USA) Company Profile 3.2.2 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Specification 3.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.3 Amgen, Inc. (USA) 3.3.1 Amgen, Inc. (USA) Company Profile 3.3.2 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Specification 3.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.4 Eli Lilly and Company (USA) 3.4.1 Eli Lilly and Company (USA) Company Profile 3.4.2 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Specification 3.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 F. Hoffmann-La Roche Ltd (Switzerland) 3.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Profile 3.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Specification 3.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 Genentech, Inc. (USA) 3.6.1 Genentech, Inc. (USA) Company Profile 3.6.2 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Specification 3.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.7 GlaxoSmithKline plc. (UK) 3.7.1 GlaxoSmithKline plc. (UK) Company Profile 3.7.2 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Specification 3.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.8 Janssen Biologics B.V. (USA) 3.8.1 Janssen Biologics B.V. (USA) Company Profile 3.8.2 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Specification 3.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.9 Actelion Pharmaceuticals 3.9.1 Actelion Pharmaceuticals Company Profile 3.9.2 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Specification 3.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.10 AstraZeneca Plc. (UK) 3.10.1 AstraZeneca Plc. (UK) Company Profile 3.10.2 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Specification 3.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.11 Boehringer Ingelheim GmbH (Germany) 3.11.1 Boehringer Ingelheim GmbH (Germany) Company Profile 3.11.2 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Specification 3.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.12 Bristol-Myers Squibb Company (USA) 3.12.1 Bristol-Myers Squibb Company (USA) Company Profile 3.12.2 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Specification 3.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.13 Allergan, Inc. (USA) 3.13.1 Allergan, Inc. (USA) Company Profile 3.13.2 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Specification 3.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.14 Novartis AG (Switzerland) 3.14.1 Novartis AG (Switzerland) Company Profile 3.14.2 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Specification 3.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.15 Novo Nordisk A/S (Denmark) 3.15.1 Novo Nordisk A/S (Denmark) Company Profile 3.15.2 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Specification 3.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.16 Pfizer, Inc. (USA) 3.16.1 Pfizer, Inc. (USA) Company Profile 3.16.2 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Specification 3.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.17 Sanofi S.A (France) 3.17.1 Sanofi S.A (France) Company Profile 3.17.2 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Specification 3.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.18 Shionogi Inc. (USA) 3.18.1 Shionogi Inc. (USA) Company Profile 3.18.2 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Specification 3.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.19 Shire Pharmaceuticals Group Plc. (UK) 3.19.1 Shire Pharmaceuticals Group Plc. (UK) Company Profile 3.19.2 Shire Pharmaceuticals Group Plc. (UK) Pediatric Drugs and Vaccines Product Specification 3.19.3 Shire Pharmaceuticals Group Plc. (UK) Pediatric Drugs and Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global Pediatric Drugs and Vaccines Market Competition by Market Players 4.1 Global Pediatric Drugs and Vaccines Production Capacity Market Share by Market Players (2016-2021) 4.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Market Players (2016-2021) 4.3 Global Pediatric Drugs and Vaccines Average Price by Market Players (2016-2021) 5 Global Pediatric Drugs and Vaccines Production by Regions (2016-2021) 5.1 North America 5.1.1 North America Pediatric Drugs and Vaccines Market Size (2016-2021) 5.1.2 Pediatric Drugs and Vaccines Key Players in North America (2016-2021) 5.1.3 North America Pediatric Drugs and Vaccines Market Size by Type (2016-2021) 5.1.4 North America Pediatric Drugs and Vaccines Market Size by Application (2016-2021) 5.2 East Asia 5.2.1 East Asia Pediatric Drugs and Vaccines Market Size (2016-2021) 5.2.2 Pediatric Drugs and Vaccines Key Players in East Asia (2016-2021) 5.2.3 East Asia Pediatric Drugs and Vaccines Market Size by Type (2016-2021) 5.2.4 East Asia Pediatric Drugs and Vaccines Market Size by Application (2016-2021) 5.3 Europe 5.3.1 Europe Pediatric Drugs and Vaccines Market Size (2016-2021) 5.3.2 Pediatric Drugs and Vaccines Key Players in Europe (2016-2021) 5.3.3 Europe Pediatric Drugs and Vaccines Market Size by Type (2016-2021) 5.3.4 Europe Pediatric Drugs and Vaccines Market Size by Application (2016-2021) 5.4 South Asia 5.4.1 South Asia Pediatric Drugs and Vaccines Market Size (2016-2021) 5.4.2 Pediatric Drugs and Vaccines Key Players in South Asia (2016-2021) 5.4.3 South Asia Pediatric Drugs and Vaccines Market Size by Type (2016-2021) 5.4.4 South Asia Pediatric Drugs and Vaccines Market Size by Application (2016-2021) 5.5 Southeast Asia 5.5.1 Southeast Asia Pediatric Drugs and Vaccines Market Size (2016-2021) 5.5.2 Pediatric Drugs and Vaccines Key Players in Southeast Asia (2016-2021) 5.5.3 Southeast Asia Pediatric Drugs and Vaccines Market Size by Type (2016-2021) 5.5.4 Southeast Asia Pediatric Drugs and Vaccines Market Size by Application (2016-2021) 5.6 Middle East 5.6.1 Middle East Pediatric Drugs and Vaccines Market Size (2016-2021) 5.6.2 Pediatric Drugs and Vaccines Key Players in Middle East (2016-2021) 5.6.3 Middle East Pediatric Drugs and Vaccines Market Size by Type (2016-2021) 5.6.4 Middle East Pediatric Drugs and Vaccines Market Size by Application (2016-2021) 5.7 Africa 5.7.1 Africa Pediatric Drugs and Vaccines Market Size (2016-2021) 5.7.2 Pediatric Drugs and Vaccines Key Players in Africa (2016-2021) 5.7.3 Africa Pediatric Drugs and Vaccines Market Size by Type (2016-2021) 5.7.4 Africa Pediatric Drugs and Vaccines Market Size by Application (2016-2021) 5.8 Oceania 5.8.1 Oceania Pediatric Drugs and Vaccines Market Size (2016-2021) 5.8.2 Pediatric Drugs and Vaccines Key Players in Oceania (2016-2021) 5.8.3 Oceania Pediatric Drugs and Vaccines Market Size by Type (2016-2021) 5.8.4 Oceania Pediatric Drugs and Vaccines Market Size by Application (2016-2021) 5.9 South America 5.9.1 South America Pediatric Drugs and Vaccines Market Size (2016-2021) 5.9.2 Pediatric Drugs and Vaccines Key Players in South America (2016-2021) 5.9.3 South America Pediatric Drugs and Vaccines Market Size by Type (2016-2021) 5.9.4 South America Pediatric Drugs and Vaccines Market Size by Application (2016-2021) 5.10 Rest of the World 5.10.1 Rest of the World Pediatric Drugs and Vaccines Market Size (2016-2021) 5.10.2 Pediatric Drugs and Vaccines Key Players in Rest of the World (2016-2021) 5.10.3 Rest of the World Pediatric Drugs and Vaccines Market Size by Type (2016-2021) 5.10.4 Rest of the World Pediatric Drugs and Vaccines Market Size by Application (2016-2021) 6 Global Pediatric Drugs and Vaccines Consumption by Region (2016-2021) 6.1 North America 6.1.1 North America Pediatric Drugs and Vaccines Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Pediatric Drugs and Vaccines Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Pediatric Drugs and Vaccines Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Pediatric Drugs and Vaccines Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Pediatric Drugs and Vaccines Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Pediatric Drugs and Vaccines Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Pediatric Drugs and Vaccines Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Pediatric Drugs and Vaccines Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Pediatric Drugs and Vaccines Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Pediatric Drugs and Vaccines Consumption by Countries 7 Global Pediatric Drugs and Vaccines Production Forecast by Regions (2022-2027) 7.1 Global Forecasted Production of Pediatric Drugs and Vaccines (2022-2027) 7.2 Global Forecasted Revenue of Pediatric Drugs and Vaccines (2022-2027) 7.3 Global Forecasted Price of Pediatric Drugs and Vaccines (2022-2027) 7.4 Global Forecasted Production of Pediatric Drugs and Vaccines by Region (2022-2027) 7.4.1 North America Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027) 7.4.2 East Asia Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027) 7.4.3 Europe Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027) 7.4.4 South Asia Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027) 7.4.5 Southeast Asia Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027) 7.4.6 Middle East Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027) 7.4.7 Africa Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027) 7.4.8 Oceania Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027) 7.4.9 South America Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027) 7.4.10 Rest of the World Pediatric Drugs and Vaccines Production, Revenue Forecast (2022-2027) 7.5 Forecast by Type and by Application (2022-2027) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027) 7.5.2 Global Forecasted Consumption of Pediatric Drugs and Vaccines by Application (2022-2027) 8 Global Pediatric Drugs and Vaccines Consumption Forecast by Regions (2022-2027) 8.1 North America Forecasted Consumption of Pediatric Drugs and Vaccines by Country 8.2 East Asia Market Forecasted Consumption of Pediatric Drugs and Vaccines by Country 8.3 Europe Market Forecasted Consumption of Pediatric Drugs and Vaccines by Countriy 8.4 South Asia Forecasted Consumption of Pediatric Drugs and Vaccines by Country 8.5 Southeast Asia Forecasted Consumption of Pediatric Drugs and Vaccines by Country 8.6 Middle East Forecasted Consumption of Pediatric Drugs and Vaccines by Country 8.7 Africa Forecasted Consumption of Pediatric Drugs and Vaccines by Country 8.8 Oceania Forecasted Consumption of Pediatric Drugs and Vaccines by Country 8.9 South America Forecasted Consumption of Pediatric Drugs and Vaccines by Country 8.10 Rest of the world Forecasted Consumption of Pediatric Drugs and Vaccines by Country 9 Global Pediatric Drugs and Vaccines Sales by Type (2016-2027) 9.1 Global Pediatric Drugs and Vaccines Historic Market Size by Type (2016-2021) 9.2 Global Pediatric Drugs and Vaccines Forecasted Market Size by Type (2022-2027) 10 Global Pediatric Drugs and Vaccines Consumption by Application (2016-2027) 10.1 Global Pediatric Drugs and Vaccines Historic Market Size by Application (2016-2021) 10.2 Global Pediatric Drugs and Vaccines Forecasted Market Size by Application (2022-2027) 11 Global Pediatric Drugs and Vaccines Manufacturing Cost Analysis 11.1 Pediatric Drugs and Vaccines Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Pediatric Drugs and Vaccines 12 Global Pediatric Drugs and Vaccines Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Pediatric Drugs and Vaccines Distributors List 12.3 Pediatric Drugs and Vaccines Customers 12.4 Pediatric Drugs and Vaccines Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Related reports
Non-Hodgkin Lymphoma Therapeutics Market
$2000-$6000
Acrylic Teeth Market
$3600-$7000